Dual Directional Trigger Participation Securities Based on the Performance of the Nasdaq-100 Index® due July 2, 2026
Fully and Unconditionally Guaranteed by Morgan Stanley
Principal at Risk Securities
The Dual Directional Trigger Participation Securities (the “securities”) are unsecured obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed by Morgan Stanley. The securities will pay no interest, do not guarantee any return of principal at maturity and have the terms described in the accompanying product supplement for Participation Securities, index supplement and prospectus, as supplemented or modified by this document. At maturity, if the Nasdaq-100 Index®, which we refer to as the underlying index, has appreciated in value, investors will receive the stated principal amount of their investment plus unleveraged upside performance of the underlying index, subject to the maximum upside payment at maturity. If the underlying index has depreciated in value but by no more than 40%, investors will receive the stated principal amount of their investment plus an unleveraged positive return equal to the absolute value of the percentage decline, which will effectively be limited to a positive 40% return. However, if the underlying index has depreciated in value by more than 40%, investors will be negatively exposed to the full amount of the percentage decline in the underlying index and will lose 1% of the stated principal amount for every 1% of decline, without any buffer. The securities are for investors who seek an equity index-based return and who are willing to risk their principal and forgo current income and upside above the maximum upside payment at maturity in exchange for the absolute return feature that applies to a limited range of performance of the underlying index. Investors may lose their entire initial investment in the securities. The securities are notes issued as part of MSFL’s Series A Global Medium-Term Notes program.
The securities differ from the Participation Securities described in the accompanying product supplement for Participation Securities in that the securities offer the potential for a positive return at maturity if the underlying index depreciates by up to 40%. The securities are not the Buffered Participation Securities described in the accompanying product supplement for Participation Securities. Unlike the Buffered Participation Securities, the securities do not provide any protection if the underlying index depreciates by more than 40%.
All payments are subject to our credit risk. If we default on our obligations, you could lose some or all of your investment. These securities are not secured obligations and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.
|
|
|
|
|
SUMMARY TERMS
|
Issuer:
|
Morgan Stanley Finance LLC
|
|
Guarantor:
|
Morgan Stanley
|
|
Maturity date:
|
July 2, 2026
|
|
Valuation date:
|
June 29, 2026, subject to postponement for non-index business days and certain market disruption events
|
|
Underlying index:
|
Nasdaq-100 Index®
|
|
Aggregate principal amount:
|
$
|
|
Payment at maturity:
|
If the final index value is greater than the initial index value:
$1,000 + ($1,000 × index percent change), subject to the maximum upside payment at maturity
If the final index value is less than or equal to the initial index value but is greater than or equal to the trigger level:
$1,000 + ($1,000 × absolute index return)
In this scenario, you will receive a 1% positive return on the securities for each 1% negative return on the underlying index. In no event will this amount exceed the stated principal amount plus $400.
If the final index value is less than the trigger level:
$1,000 × index performance factor
Under these circumstances, the payment at maturity will be less than the stated principal amount of $1,000, and will represent a loss of more than 40%, and possibly all, of your investment.
|
|
Maximum upside payment at maturity:
|
$1,075 per security (107.50% of the stated principal amount)
|
|
Index percent change:
|
(final index value – initial index value) / initial index value
|
|
Absolute index return:
|
The absolute value of the index percent change. For example, a –5% index percent change will result in a +5% absolute index return.
|
|
Index performance factor:
|
final index value / initial index value
|
|
Initial index value:
|
, which is the index closing value on the pricing date
|
|
Final index value:
|
The index closing value on the valuation date
|
|
Trigger level:
|
, which is 60% of the initial index value
|
|
Stated principal amount / Issue price:
|
$1,000 per security (see “Commissions and issue price” below)
|
|
Pricing date:
|
December 27, 2024
|
|
Original issue date:
|
January 2, 2025 (3 business days after the pricing date)
|
|
CUSIP / ISIN:
|
61777RRV7 / US61777RRV77
|
|
Listing:
|
The securities will not be listed on any securities exchange.
|
|
Agent:
|
Morgan Stanley & Co. LLC (“MS & Co.”), a wholly owned subsidiary of Morgan Stanley and an affiliate of MSFL. See “Supplemental information regarding plan of distribution; conflicts of interest.”
|
|
Estimated value on the pricing date:
|
Approximately $982.70 per security, or within $25.00 of that estimate. See “Investment Summary” on page 2.
|
|
Commissions and issue price:
|
Price to public(1)
|
Agent’s commissions and fees(2)
|
Proceeds to us(3)
|
Per security
|
$1,000
|
$0
|
$1,000
|
Total
|
$
|
$
|
$
|
(1)The securities will be sold only to investors purchasing the securities in fee-based advisory accounts.
(2) MS & Co. expects to sell all of the securities that it purchases from us to an unaffiliated dealer at a price of $ per security, for further sale to certain fee-based advisory accounts at the price to public of $1,000 per security. MS & Co. will not receive a sales commission with respect to the securities. See “Supplemental information regarding plan of distribution; conflicts of interest.” For additional information, see “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement for Participation Securities.
(3)See “Use of proceeds and hedging” on page 14.
The securities involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 6.
The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this document or the accompanying product supplement, index supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The securities are not deposits or savings accounts and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations of, or guaranteed by, a bank.
You should read this document together with the related product supplement, index supplement and prospectus, each of which can be accessed via the hyperlinks below. When you read the accompanying product supplement and index supplement, please note that all references in such supplements to the prospectus dated November 16, 2023, or to any sections therein, should refer instead to the accompanying prospectus dated April 12, 2024 or to the corresponding sections of such prospectus, as applicable. Please also see “Additional Terms of the Securities” and “Additional Information About the Securities” at the end of this document.
References to “we,” “us” and “our” refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context requires.
Product Supplement for Participation Securities dated November 16, 2023 Index Supplement dated November 16, 2023
Prospectus dated April 12, 2024